Beyond the Numbers: The Rebound and Current Financial State of the Biopharma and Med Tech Industries

January 12, 2022
MarketScale

 

COVID-19 rocked the world in most industries, but particularly for biopharma and pharmaceuticals, which were at the forefront. Tyler Ridley, Senior Manager of Valuation Services at Weaver, joined this episode of Weaver: Beyond The Numbers Podcast with Weaver hosts Howard Altshuler, Partner-In-Charge of Real Estate Services, and Rob Nowak, Tax Partner with Weaver, to discuss the rebound and current financial state of the biopharma and med tech industries.

Since the pandemic, the spike in healthcare initial public offerings (IPOs) and performance solidified the IPO pathway and exit strategy for life science investors. “I think it’s a shift in the narrative in biopharma and medical technology from profit-driven industries characterized by nefarious price gouging executives to more strategic industries that really came to the aid of the government and society more broadly in a time of crisis,” Ridley added.

While there were deal drop-offs in 2020 because of factors like the lack of elective surgeries, there was an increase in 2021 deals for digital therapeutics and delivery of care models. MedTech is just one example of this. “MedTech’s deal value has also exceeded 2020 totals so far and is on pace to be the highest value since 2017 despite a decline in total deal volume which indicates that the value per deal on average is increasing,” stated Ridley.

The M&A market has been muted this year, which is related to concerns with regulatory action to curb pricing power and lower drug prices. Risk tolerance to acquire other companies is not as favorable as it is to license their technology.

As for M&A activity for the rest of 2021, valuations are high, making it difficult for executives to gain acquisitions. The turbulent regulation environment combined with the lack of an FDA head is also hard to cope with. Additionally, the current supply chain issue may result in vertical acquisitions boosting M&A activity.

For more podcasts, whitepapers, and thought leadership on this topic, visit weaver.com.

Recent Episodes

hydrogen energy
View episode

As the world confronts climate change and searches for sustainable energy sources, hydrogen has emerged as a promising solution to reduce carbon emissions. With global energy demands rising and industries like shipping and manufacturing grappling with decarbonization, hydrogen is gaining attention. A key driver of this transition is the Inflation Reduction Act, which has…

side hustle
View episode

Balancing professional success with personal well-being is a common struggle for many in today’s fast-paced world. As side hustles and entrepreneurial ventures gain popularity, many people are seeking ways to advance their careers without sacrificing their personal lives. Recent research shows that burnout is a significant issue in the workforce—67% of workers in the…

internal operating system
View episode

The pressure to perform in today’s fast-paced world has underscored an important realization: external success isn’t enough. With burnout rates on the rise, more individuals and organizations are turning inward, recognizing that true effectiveness comes from reprogramming their internal operating systems. Research from the HeartMath Institute shows that aligning the heart, mind, and emotions,…